Wharton's jelly MSC & exosome programs for post-TBI neurological recovery
Stem cell therapy for traumatic brain injury in Istanbul, Turkey
How our Istanbul medical team led by Uzm. Dr. Cihan Bolat reviews your brain imaging and rehabilitation progress to design a multi-route regenerative protocol.
Condition-specific editorial anatomy. Explanatory labels remain in accessible text.
Understanding the condition
Understanding the condition and our regenerative approach
After the initial hospital stabilization of a traumatic brain injury (TBI), the brain often enters a prolonged secondary phase where chronic microglial inflammation, diffuse axonal strain, microvascular disruption, and oxidative stress continue to impede recovery. Even months or years after the trauma, this persistent neuro-inflammatory environment can limit synaptic remodeling and leave patients struggling with motor coordination, balance, speech, cognitive stamina, concentration, or emotional regulation.
Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) and WJ-MSC-derived exosomes are investigated in post-acute and chronic TBI to quiet this secondary inflammatory cascade and reactivate the biological conditions for neuroplasticity. Inside the central nervous system and systemic vasculature, WJ-MSCs and nanoscale exosomes work to downregulate pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) and shift chronically activated M1 microglia toward a reparative M2 phenotype that supports tissue remodeling rather than scar-forming gliosis. Simultaneously, they release a rich spectrum of neurotrophic and angiogenic factors—including BDNF, GDNF, NGF, and VEGF—alongside regenerative exosomal microRNAs that promote synaptogenesis, support oligodendrocyte myelin repair along white-matter tracts, enhance perilesional capillary perfusion, and restore mitochondrial energy balance in recovering neurons.
At our Istanbul clinic led by Uzm. Dr. Cihan Bolat, we evaluate your brain MRI or CT scans, injury timeline, neurological examination, and current rehabilitation goals to design a tailored multi-route protocol combining intrathecal, intravenous, and intranasal administration. Paired with active physical, occupational, and cognitive neurorehabilitation, our program aims to support motor control, clearer speech and cognition, improved mental stamina, and greater daily independence.
Reviewed by: Uzm. Dr. Cihan Bolat · Reviewed · Re-review due
What happens inside the body
Key biological processes and therapeutic targets
Long after the primary mechanical impact of TBI, secondary microglial activation, axonal demyelination, blood-brain barrier dysfunction, and insufficient neurotrophic signaling can stall functional recovery—processes directly targeted by multi-route WJ-MSC and exosome therapy.
What our protocol aims to support
- Modulating chronic post-traumatic neuroinflammation: Our WJ-MSC and exosome protocols aim to quiet persistent pro-inflammatory glial signaling so recovering neural circuits face less biological stress.
- Supporting neuroplasticity & synaptic remodeling: Paracrine neurotrophic factors (BDNF, GDNF) and exosomal microRNAs aim to support axonal resilience, myelin maintenance, and synaptic adaptation alongside active neurorehabilitation.
- Promoting cerebral microvascular & metabolic balance: Systemic and central biologics aim to support vascular endothelial health, blood-brain barrier stability, and tissue oxygenation across recovering brain regions.
- Coordinated with your ongoing neurorehabilitation & medications: Every Istanbul protocol is designed to complement your physical, occupational, and speech therapy as well as any prescribed neurological medications.
- 01
Persistent secondary microglial inflammation
After the primary mechanical trauma subsides, activated M1 microglia can continue releasing TNF-α, IL-1β, and free radicals across injured cortical and subcortical zones, causing ongoing bystander stress and cognitive fatigue. Wharton's jelly MSCs and their exosomes release immunomodulatory cytokines (IL-10, TGF-β) that polarize microglia toward a neuroprotective M2 phenotype. This transition calms chronic inflammatory signaling and reduces reactive astrogliosis around the injury zone. Quieting secondary neuroinflammation reopens a healthier window for neural circuit recovery.
- 02
Diffuse axonal & white-matter tract stress
Rotational and shearing forces during TBI stretch long white-matter axons and damage the oligodendrocytes that maintain their insulating myelin sheaths, slowing signal transmission between brain regions. WJ-MSCs and WJ-MSC exosomes deliver neurotrophic factors (BDNF, NGF, GDNF) and myelin-supportive microRNAs that nourish oligodendrocyte progenitor cells and stabilize axonal cytoskeletons. By supporting remyelination signaling and metabolic transport along surviving tracts, biological therapy helps improve communication across motor, sensory, and executive networks. Stronger white-matter connectivity supports smoother coordination and faster processing speed.
- 03
Cerebrovascular & blood-brain barrier remodeling
Traumatic injury disrupts local capillary networks and compromises the blood-brain barrier, leaving perilesional brain tissue chronically under-perfused and metabolically stressed. Intravenous and intrathecal WJ-MSCs secrete VEGF, angiopoietins, and endothelial growth factors that promote microvascular repair and tight-junction integrity. Restoring healthy microcirculation increases oxygen and glucose delivery to dormant 'penumbra' neurons surrounding the original injury site. Improved neurovascular perfusion provides the metabolic fuel required for active rehabilitation.
- 04
Synaptic plasticity & neurotrophic demand
Functional recovery after TBI relies on neuroplasticity—the ability of uninjured neurons to sprout new dendrites, form fresh synapses, and take over functions previously handled by damaged areas. This reorganization demands high levels of BDNF, synapsin-supportive proteins, and mitochondrial energy that are often depleted in the injured brain. WJ-MSC exosomes transfer regenerative microRNAs and trophic proteins that upregulate synaptic plasticity genes and support neuronal bioenergetics. Pairing this trophic surge with structured physical and speech therapy helps consolidate new functional pathways.
Why regenerative medicine is investigated
Scientific rationale for Wharton's jelly MSCs and exosomes
Breaking the Cycle of Chronic Post-Traumatic Neuroinflammation
Following a traumatic brain injury, microglia and astrocytes in perilesional and diffuse white-matter tracts can remain locked in an inflammatory state for years. This chronic neuroinflammation creates a biochemical barrier that prevents surviving neurons from forming new synaptic detours during rehabilitation. Regenerative biologics aim to calm this persistent glial hostility and clear inflammatory signaling from the neural microenvironment. Creating a quieter, trophic-rich brain environment allows surviving neural circuits to respond more effectively to physical and cognitive training.
How WJ-MSCs & Exosomes Drive Neuroplasticity & Axonal Repair
Wharton's jelly MSCs secrete potent levels of brain-derived neurotrophic factor (BDNF), GDNF, and VEGF that stimulate dendritic branching, synaptic remodeling, and perilesional angiogenesis. Alongside the cells, nanoscale WJ-MSC exosomes cross the blood-brain barrier and penetrate deep cortical and subcortical structures, delivering neuroprotective microRNAs and proteins to stressed neurons and oligodendrocytes. This vesicular signaling helps stabilize damaged white-matter myelin sheaths, reduce astroglial scar signaling, and boost neuronal mitochondrial ATP production. Together, they provide the biological building blocks that support functional brain reorganization.
Phase-Matched Multi-Route Protocols in Istanbul
Uzm. Dr. Cihan Bolat and our medical team review your acute hospital records, current brain MRI/CT, seizure or shunt history, and rehabilitation baseline before planning your visit. By combining intrathecal CSF delivery, intravenous systemic infusion, and intranasal exosome administration, our protocol targets both central perilesional circuits and systemic neuro-immune balance. Every treatment plan is coordinated with your ongoing neurorehabilitation and prescribed neurological medications.
Our treatment approach & administration routes
How our proposed Wharton's jelly MSC and exosome protocols work
- 01
Intrathecal WJ-MSC Administration
Intrathecal administration delivers Wharton's jelly MSCs directly into the cerebrospinal fluid—performed with or without sedation depending on clinical circumstances—so the cells bypass the blood-brain barrier and circulate through the subarachnoid space. Within the CSF, WJ-MSCs release BDNF, GDNF, VEGF, and anti-inflammatory cytokines that diffuse toward injured cortical, subcortical, and brainstem structures. This direct central route aims to calm chronic microglial inflammation and stimulate synaptic and white-matter plasticity across recovering brain networks. Our team carefully screens brain imaging and intracranial stability before scheduling intrathecal delivery.
Role in your protocolOur medical team determines the exact Wharton's jelly MSC and exosome combination, dosage, and administration route after evaluating your medical history and reports.
- 02
Intravenous WJ-MSC Administration
Intravenous infusion introduces Wharton's jelly MSCs into the systemic circulation to regulate peripheral immune activation and support cerebrovascular endothelial health. After TBI, chronic systemic-to-central immune cross-talk can perpetuate neuroinflammation and vascular fatigue; intravenous MSCs help shift circulating immune cells toward a regulatory, anti-inflammatory profile. At the same time, systemic paracrine factors support blood-brain barrier repair and microvascular perfusion. Combining intravenous and intrathecal routes mirrors published clinical protocols for post-TBI recovery.
Role in your protocolOur medical team determines the exact Wharton's jelly MSC and exosome combination, dosage, and administration route after evaluating your medical history and reports.
- 03
Intravenous WJ-MSC Exosome Administration
Intravenous WJ-MSC exosome administration delivers billions of nanoscale extracellular vesicles loaded with neuroprotective proteins, growth factors, and microRNAs that promote axonal and synaptic repair. Because exosomes effortlessly cross the blood-brain barrier, they reach diffuse white-matter tracts and perilesional neurons to support mitochondrial ATP production and oligodendrocyte myelin maintenance. Exosomal signaling provides immediate intercellular instructions that help quiet oxidative and inflammatory stress. This route complements cellular therapy by delivering concentrated vesicular cargo throughout the brain's microcirculation.
Role in your protocolOur medical team determines the exact Wharton's jelly MSC and exosome combination, dosage, and administration route after evaluating your medical history and reports.
- 04
Intranasal Exosome Administration
Intranasal administration offers a gentle, non-invasive route investigated for delivering WJ-MSC exosomes along the olfactory and trigeminal pathways toward the frontal lobes, limbic system, and brainstem. Because frontal and executive networks are frequently affected in traumatic brain injury, intranasal dosing provides a comfortable supplementary corridor to support central trophic signaling. While the exact fraction of intranasal exosomes reaching specific human brain regions remains under ongoing clinical study, it integrates seamlessly with intravenous and intrathecal administrations during your stay in Istanbul.
Role in your protocolOur medical team determines the exact Wharton's jelly MSC and exosome combination, dosage, and administration route after evaluating your medical history and reports.
What we aim to achieve
Therapeutic objectives and functional outcomes we track
Before treatment in Istanbul, our physicians establish your clinical baseline and define realistic biological and functional objectives to track during follow-up.
- 01
Motor Control, Balance & Coordination
Tracking gait stability, trunk posture, spasticity reduction, and fine hand dexterity alongside your physical and occupational therapy. By supporting white-matter tract signaling and synaptic remodeling, the protocol aims to help patients achieve smoother, more controlled movement.
- 02
Cognitive Stamina, Attention & Processing Speed
Monitoring mental endurance, focus, short-term memory, and reduced brain fog during daily tasks. Calming chronic microglial inflammation and supporting cerebral microcirculation aims to help the brain sustain clearer cognitive focus without rapid exhaustion.
- 03
Speech Clarity, Swallowing & Daily Independence (FIM / GOSE)
Assessing expressive communication, vocal control, swallowing safety, and Functional Independence Measure milestones. Neurotrophic support alongside speech and occupational therapy aims to strengthen practical self-care and social participation.
- 04
Sleep Quality, Headache Relief & Mood Stability
Evaluating post-traumatic headache frequency, sleep continuity, and emotional balance. Regulating neuro-immune excitability and autonomic tone helps create a steadier foundation for restorative sleep and daily recovery.
How treatment is personalized
How our medical team evaluates your records and designs your protocol
How our Istanbul medical team led by Uzm. Dr. Cihan Bolat reviews your brain imaging and rehabilitation progress to design a multi-route regenerative protocol.
Medical history & reports we request
- Date and mechanism of injury, acute hospital summary, and current stability
- Recent brain MRI or CT report and neurological examination findings
- History of seizures, cranial surgery, shunts, or anticoagulation therapy
- Current physical, occupational, or speech rehabilitation notes
- Review by Uzm. Dr. Cihan Bolat to confirm suitability for intrathecal and IV routes
Clinical suitability & protocol checks
- Patients must be medically and neurosurgically stable past the acute hospital phase before planning international travel to Istanbul.
- All prescribed anti-seizure, spasticity, and neurological medications remain uninterrupted throughout your treatment program.
- We coordinate accessible airport transfers, caregiver accommodation support, and a clear post-treatment rehabilitation timeline.
What the patient journey looks like
From your first inquiry to individualized treatment in Istanbul
- 01
Contact us & share your medical reports
Reach out regarding your condition and share your medical history, diagnosis, imaging, and relevant lab reports via our secure form or WhatsApp.
- 02
Medical team evaluation & protocol design
Our medical team evaluates your records and, where clinically appropriate, develops an individualized Wharton's jelly MSC and exosome protocol.
- 03
Transparent explanation of protocol & costs
We explain the proposed treatment, specific biologics, administration routes, intended therapeutic objectives, stay timeline, and itemized costs.
- 04
Arrange treatment in Istanbul & follow-up
Review your individualized proposal, schedule your visit to Istanbul with private airport and clinic transfers, and continue with structured 1, 3, and 6-month follow-up.
2026 cost & protocol planning
Transparent Istanbul pricing tailored to your protocol
After our medical team evaluates your records, we provide a written proposal explaining the recommended Wharton's jelly MSC and exosome preparations, administration routes, intended objectives, stay timeline, and itemized costs.
For 2026 planning context, targeted exosome and local orthopedic protocols typically range from $3,500–$6,500, while comprehensive Wharton's jelly MSC and exosome programs range from $7,000–$18,000. Your exact cost is confirmed after your medical evaluation.
- Patients must be medically and neurosurgically stable past the acute hospital phase before planning international travel to Istanbul.
- All prescribed anti-seizure, spasticity, and neurological medications remain uninterrupted throughout your treatment program.
- We coordinate accessible airport transfers, caregiver accommodation support, and a clear post-treatment rehabilitation timeline.
What your written treatment proposal explains
- 01
Which Wharton's jelly MSC, exosome, or combined protocol is proposed for your condition?
- 02
Which administration routes are recommended and how do they work biologically?
- 03
What are the intended therapeutic objectives and expected stay length in Istanbul?
- 04
What is the itemized cost and how does 1, 3, and 6-month follow-up work after treatment?
Evidence & important considerations
Published clinical research and important considerations
Below is a summary of published human studies, investigated mechanisms, and important limitations relevant to regenerative medicine for this condition.
01 Six-patient Wharton's jelly MSC phase 1 TBI study
Open study- Product
- Wharton's jelly-derived mesenchymal stromal cells
- Route
- Combined intrathecal, intramuscular, and intravenous administrations
- Study design
- Phase 1 clinical study with longitudinal pre- and post-intervention tracking
- Finding
- The clinical study reported that multi-route Wharton's jelly MSC administration was well tolerated with only transient minor effects and documented within-participant functional score gains over one-year follow-up.
- Limitation
- Because early-phase studies involve small cohorts alongside ongoing rehabilitation, individualized medical evaluation and realistic functional milestones remain essential.
Scientific references
Clinical studies and scientific references
FAQ
Frequently asked questions about this treatment
Request Free Medical Evaluation
Begin a personalized treatment conversation with our medical team.
Share your case in confidence. Our international coordinators review every enquiry and respond within 24 hours, in your language.